SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018

February 28, 2019
Source: MMWR. Morbidity and Mortality Weekly Report ; v. 68, no. 4

[PDF-349.78 KB]

English

Details Related Documents You May Also Like

Details:

Description:

Supplements: Post-licensure safety Surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United States, October 2017–June 2018
Subjects:

[+]

Adverse Drug Reaction Reporting Systems
Source:

MMWR. Morbidity and Mortality Weekly Report ; v. 68, no. 4
Document Type:

Journal Article
Name as Subject:

Vaccine Adverse Events Reporting System ; Vaccine Adverse Events Reporting System

Vaccine Adverse Events Reporting System ; Vaccine Adverse Events Reporting System Less -
Genre:

Tables
Place as Subject:

United States
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:7cdaf9dbac0f524d7829543e89d18d780b736b486acb3674866a144a0a6a3e3f
Download URL:

https://stacks.cdc.gov/view/cdc/61561/cdc_61561_DS1.pdf
File Type:

No Additional Files

More +

SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018

Details:

Supporting Files

Related Documents

You May Also Like